摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

三氟甲磺酸己酯 | 53059-88-4

中文名称
三氟甲磺酸己酯
中文别名
——
英文名称
hexyl triflate
英文别名
n-hexyl triflate;hexyl trifluoromethanesulfonate;Methanesulfonic acid, trifluoro-, hexyl ester
三氟甲磺酸己酯化学式
CAS
53059-88-4
化学式
C7H13F3O3S
mdl
——
分子量
234.24
InChiKey
TZHLRBCSJJHPSC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    64-65 °C(Press: 1 Torr)
  • 密度:
    1.246±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    14
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    6

SDS

SDS:4d5e6bd7c9da76cd6741e71bced422c5
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    三氟甲磺酸己酯 在 lithium hydroxide 、 lithium aluminium tetrahydride 、 双氧水sodium hexamethyldisilazane 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 11.5h, 生成 (R)-2-methyloctan-1-ol
    参考文献:
    名称:
    Total synthesis and structure assignment of the antitumor antibiotic aranorosin
    摘要:
    The structurally unique antifungal and antitumor antibiotic aranorosin was prepared in a convergent, stereoselective sequence. Oxidative cyclization of N-protected L-tyrosine, followed by face-selective 1,2-addition of [(benzyloxy)methyl]lithium, Henbest oxidation in the presence of Kishi's radical inhibitor, and simultaneous N,O-deprotection led to an amino diol which was N-acylated with the fatty acid side-chain segment. After a low-temperature reduction of the lactone moiety to the lactol, the carbonyl function was regenerated under neutral conditions by diol cleavage with sodium periodate. Preparation of the acid side chain involved a diastereoselective imide alpha-alkylation directed by Evans' oxazolidinone auxiliary, followed by a series of Wittig-Horner chain extensions. Since the relative configuration at the C (6') position of the natural product had not been determined, we prepared both the (6'S) and the (6'R) isomers of aranorosin. Comparison of synthetic material with the reported spectral data for natural (-)-aranorosin, especially H-1 and C-13 NMR and [alpha]D, did not allow a definitive assignment. After purification of a sample of the isolated material from Pseudoarachniotus roseus, the corrected [alpha]D strongly indicated the (6'R)-stereochemistry for the natural compound. This assignment was confirmed by circular dichroism spectra for (6'S)- and (6'R)-aranorosin and the natural material.
    DOI:
    10.1021/jo00077a050
  • 作为产物:
    描述:
    1-碘己烷silver trifluoromethanesulfonate 作用下, 以 为溶剂, 以2.13 g (91%)的产率得到三氟甲磺酸己酯
    参考文献:
    名称:
    Preparation of aliphatic perchlorates and of trifluoromethane sulfonates
    摘要:
    通过在苯中将相应的银盐与一次脂肪烃卤化物在约5度C至约50度C的温度下反应,主要形成主要一次脂肪烃酸高氯酸盐和三氟乙烷磺酸盐。主要一次脂肪烃酸高氯酸盐和三氟甲磺酸盐是优秀的胺、醇和硝基醇的烷基化试剂。
    公开号:
    US04165332A1
点击查看最新优质反应信息

文献信息

  • Application of a Flexible Synthesis of (5<i>R</i>)-Thiolactomycin To Develop New Inhibitors of Type I Fatty Acid Synthase
    作者:Jill M. McFadden、Susan M. Medghalchi、Jagan N. Thupari、Michael L. Pinn、Aravinda Vadlamudi、Katherine I. Miller、Francis P. Kuhajda、Craig A. Townsend
    DOI:10.1021/jm049389h
    日期:2005.2.1
    Fatty acid synthase (FAS) catalyzes the synthesis of palmitate from the sequential condensation of an acetyl primer with two carbon units added from malonyl-CoA. Inhibition of the beta-ketoacyl synthase domain of mammalian FAS leads to selective cytotoxicity to various cancer cell lines in vitro and in vivo. Also, inhibitors of FAS can cause reduced food intake and body weight in mice. Naturally occurring
    脂肪酸合酶(FAS)催化乙酰基引物与丙二酰辅酶A加成的两个碳单元的顺序缩合,从而合成棕榈酸酯。哺乳动物FAS的β-酮酰基合酶结构域的抑制导致在体外和体内对多种癌细胞的选择性细胞毒性。同样,FAS抑制剂可导致小鼠食物摄入减少和体重下降。天然存在的硫菌素(TLM)被用作开发新型I型FAS抑制剂的模板。使用灵活的合成方法,获得了具有选择性FAS活性并显示出抗癌和减肥效果的TLM结构类似物家族。化合物13a和13d抑制纯FAS(ZR-75-1乳腺癌,IC(50)=50微克/毫升),并在BalbC小鼠中显示出有效的体重减轻(> 5%)。TLM衍生物的另一个子类(23b-d,31a)具有FAS活性(IC(50)=5%),并且对癌细胞具有细胞毒性(IC(50)<38 microg / mL)。最后,第三个子类(16b,29,30)对FAS也有效(IC(50)=
  • [EN] NOVEL COMPUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME<br/>[FR] NOUVEAUX COMPOSÉS, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET MÉTHODES D'UTILISATION DESDITS COMPOSÉS
    申请人:FASGEN INC
    公开号:WO2004005277A1
    公开(公告)日:2004-01-15
    A pharmaceutical composition comprising a phamaceurtical diluent and a compound of formula IV wherein R21= H, C1-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, -CH2OR25, -C(O)R25, -CO(O)R25, -C(O)NR25R26, -CH2C(O)R25, or -CH2C(O)NHR25, where R25 and R26 are each independently H, C1-C10 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, optionally containing one or more halogen atoms. R22 = -OH, -OR27, -OCH2C(O)R27, -OCH2C(O)NHR27, -OC(O)R27, -OC(O)OR27, -OC(O)NHNH-R5, or -OC(O)NR27R28, where R27 and R28 are each independentlyH, C1 -C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl, and where R27 and R28 can each optionally contain halogen atoms; R23 and R24, the same or different from each other, are C1-C20 alkyl, cycloalkyl, alkenyl, aryl, arylalkyl, or alkylaryl. Methods of using such formulations for the treatment of cancer, to effect weight loss, to treat microbially-based infections, to inhibit neuropeptide-Y and/or fatty acid synthase, and to stimulate CPT-1.
    一种包括药用稀释剂和化合物IV的药物组合物,其中R21= H,C1-C20烷基,环烷基,烯基,芳基,芳基烷基或烷基芳基,-CH2OR25,-C(O)R25,-CO(O)R25,-C(O)NR25R26,-CH2C(O)R25或-CH2C(O)NHR25,其中R25和R26各自独立地为H,C1-C10烷基,环烷基,烯基,芳基,芳基烷基或烷基芳基,可选地含有一个或多个卤素原子。R22 = -OH,-OR27,-OCH2C(O)R27,-OCH2C(O)NHR27,-OC(O)R27,-OC(O)OR27,-OC(O)NHNH-R5或-OC(O)NR27R28,其中R27和R28各自独立地为H,C1-C20烷基,环烷基,烯基,芳基,芳基烷基或烷基芳基,且R27和R28各自可选地含有卤素原子;R23和R24,相同或不同,为C1-C20烷基,环烷基,烯基,芳基,芳基烷基或烷基芳基。使用这种配方治疗癌症,减轻体重,治疗微生物感染,抑制神经肽Y和/或脂肪酸合酶,以及刺激CPT-1的方法。
  • Arene-catalysed lithiation of triflates and triflamides under barbier-type conditions: An indirect transformation of alcohols and amines into organolithium compounds
    作者:Emma Alonso、Diego J Ramón、Miguel Yus
    DOI:10.1016/0040-4020(96)00886-1
    日期:1996.11
    The reaction of alkyl triflates 1 or allyl or benzyl triflamides 3 with an excess of lithium powder and a catalytic amount of naphthalene (4 mol %) in the presence of different electrophiles [Me3SiCl, PriCHO, ButCHO, PhCHO, 4-MeOC6H4CHO, CH3(CH2)6CHO, Et2CO, (CH2)5CO, (c-C3H5)2CO, PhCOMe, 4-MeC6H4COPh, PhCH=NPh, n-C8H7CON(CH2)4] in THF at temperature ranging between −78 and 0°C leads, after hydrolysis
    烷基三氟甲磺酸酯的反应1或烯丙基或苄基triflamides 3在不同的亲电子[我的存在下用过量的锂粉末和萘的催化量的(4摩尔%)3的SiCl,镨我CHO,卜吨CHO,苯甲醛, 4-MeOC 6 H 4 CHO,CH 3(CH 2)6 CHO,Et 2 CO,(CH 2)5 CO,(c -C 3 H 5)2 CO,PhCOMe,4-MeC 6 H 4 COPh,PhCH = NPh,n -C在-78至0°C之间的温度下,在THF中的8 H 7 CON(CH 2)4 ]导致水解后生成相应的缩合产物2。当将α,β-不饱和羰基化合物用作亲电子化合物时,取决于所使用的亲电子试剂,发生1,2-(2-环己烯酮)或1,4-加成(肉桂醛或亚苄基丙酮)。
  • TUMOR-TARGETING EVALUATION METHODOLOGY AND COMPOUNDS RELATED THERETO
    申请人:GOURDEAU Henriette
    公开号:US20090062255A1
    公开(公告)日:2009-03-05
    The invention relates to a method for evaluating a chemotherapeutic potential of a candidate molecule. In evaluating the candidate molecule, the candidate molecule is tested for its ability to inhibit the in vitro growth of a cancer cell; to bind a cellular receptor produced by a cancer cell, wherein said receptor, such as a peripheral benzodiazepine receptor, is produced in a greater amount by said cancer cell than by a normal cell; and to inhibit the activity of at least one protein member of the MAPK pathway. The invention further relates to dibenzodiazepinone analogues and derivatives thereof.
    该发明涉及一种评估候选分子化疗潜力的方法。在评估候选分子时,将测试候选分子抑制癌细胞体外生长的能力;结合由癌细胞产生的细胞受体,其中所述受体,如外周苯二氮卓受体,由所述癌细胞产生的数量比正常细胞多;并抑制MAPK通路中至少一个蛋白质成员的活性。该发明还涉及二苯二氮卓酮类似物及其衍生物。
  • Reversal of Tabun Toxicity Enabled by a Triazole‐Annulated Oxime Library—Reactivators of Acetylcholinesterase
    作者:Zrinka Kovarik、Jarosław Kalisiak、Nikolina Maček Hrvat、Maja Katalinić、Tamara Zorbaz、Suzana Žunec、Carol Green、Zoran Radić、Valery V. Fokin、K. Barry Sharpless、Palmer Taylor
    DOI:10.1002/chem.201805051
    日期:2019.3.15
    and for post‐exposure treatment is a continued challenge. In this study, we analyzed the reactivation potency of 111 novel nucleophilic oximes mostly synthesized using the CuAAC triazole ligation between alkyne and azide building blocks. We identified several oximes with significantly improved in vitro reactivating potential for tabun‐inhibited human AChE, and in vivo antidotal efficacies in tabun‐exposed
    乙酰胆碱酯酶(AChE)是一种降解神经递质乙酰胆碱的酶,当被有机磷化合物(OPs)(例如神经毒剂和杀虫剂)共价抑制时,可以被肟重新激活。然而,由于标准吡啶鎓醛肟肟解毒剂的低活化作用,塔邦仍然是最危险的神经制剂之一。因此,寻找最佳的活化剂来预防塔宾毒性和进行暴露后治疗仍然是一个挑战。在这项研究中,我们分析了炔烃和叠氮化物结构单元之间主要通过CuAAC三唑连接而合成的111种新型亲核肟的活化潜能。我们鉴定了几种肟,它们在禁忌暴露的人AChE中具有显着提高的体外再激活潜力,并且在禁忌暴露的小鼠中具有体内解毒作用。
查看更多